Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups

Muslima Ejaz1, Amna Rehana Siddiqui, Yasraba Rafiq

  • 1Department of Pathology and Microbiology, Aga Khan University, Stadium Road, Karachi, Pakistan.

Insights

Multidrug-resistant tuberculosis (MDR-TB) affects 5.0% of patients in Karachi. Female gender and prior incomplete treatment are significant risk factors for MDR-TB, highlighting the need for targeted prevention strategies.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health threat.
  • Pakistan has a high tuberculosis prevalence but lacks data on drug-resistant TB.
  • Understanding MDR-TB prevalence and risk factors is crucial for effective control strategies.

Purpose of the Study:

  • To estimate the prevalence of multidrug-resistant tuberculosis (MDR-TB) in Karachi.
  • To identify risk factors associated with MDR-TB in patients with pulmonary tuberculosis.

Main Methods:

  • A study involving 640 adult patients with pulmonary tuberculosis was conducted in Karachi from July 2006 to August 2008.
  • Passive case finding was employed, and MDR-TB prevalence was calculated using Epi-Info.
  • Logistic Regression analysis was used to determine risk factors associated with MDR-TB.

Main Results:

  • The overall prevalence of MDR-TB was 5.0% (95% CI: 3.3-6.6%), with higher rates in previously treated patients (17.9%) compared to untreated patients (2.3%).
  • Independent risk factors for MDR-TB included female gender (OR 3.12) and a history of incomplete treatment (OR 10.1).
  • Specific ethnic groups, Sindhis (OR 4.5) and Pashtoons (OR 3.6), showed higher risk for MDR-TB.

Conclusions:

  • The study established a 5.0% MDR-TB rate in the studied population in Karachi.
  • There is a critical need to enhance MDR-TB prevention efforts.
  • Strategies should include strengthening Directly Observed Treatment, Short-course (DOTS) delivery, with a focus on women and high-risk ethnic groups.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...